B. Riley Securities Maintains Buy on WAVE Life Sciences, Lowers Price Target to $22
Benzinga Newsdesk 3 months ago
Analyst RatingsNewsPrice Target
B. Riley Securities analyst Madison El-Saadi maintains WAVE Life Sciences (NASDAQ:WVE) with a Buy and lowers the price target from $31 to $22.
B. Riley Securities analyst Madison El-Saadi maintains WAVE Life Sciences (NASDAQ:WVE) with a Buy and lowers the price target from $31 to $22.